Assessing the in vivo targeting efficiency of multifunctional nanoconstructs bearing antibody-derived ligands.
about
Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigmNanoparticle mediated drug delivery of rolipram to tyrosine kinase B positive cells in the inner ear with targeting peptides and agonistic antibodies.Polyol synthesis, functionalisation, and biocompatibility studies of superparamagnetic iron oxide nanoparticles as potential MRI contrast agents.Development of 99mTc-radiolabeled nanosilica for targeted detection of HER2-positive breast cancer.Facile method for the site-specific, covalent attachment of full-length IgG onto nanoparticlesTumor cell targeting by iron oxide nanoparticles is dominated by different factors in vitro versus in vivo.Antibody fragments as nanoparticle targeting ligands: a step in the right directionAddressing challenges of heterogeneous tumor treatment through bispecific protein-mediated pretargeted drug delivery.Nanometronomic treatment of 4T1 breast cancer with nanocaged doxorubicin prevents drug resistance and circumvents cardiotoxicity.Incorporating gold nanoclusters and target-directed liposomes as a synergistic amplified colorimetric sensor for HER2-positive breast cancer cell detectionAntibody-targeted biodegradable nanoparticles for cancer therapy.Bridging the Knowledge of Different Worlds to Understand the Big Picture of Cancer Nanomedicines.Targeting FR-expressing cells in ovarian cancer with Fab-functionalized nanoparticles: a full study to provide the proof of principle from in vitro to in vivo.Tumor-targeted nanomedicines for cancer theranostics.Nano-targeting of mucosal addressin cell adhesion molecule-1 identifies bowel inflammation foci in murine model.Bioengineered gold nanoparticles targeted to mesenchymal cells from patients with bronchiolitis obliterans syndrome does not rise the inflammatory response and can be safely inhaled by rodents.Trastuzumab- and Fab' fragment-modified curcumin PEG-PLGA nanoparticles: preparation and evaluation in vitro and in vivo.Multivalent exposure of trastuzumab on iron oxide nanoparticles improves antitumor potential and reduces resistance in HER2-positive breast cancer cells.A prospective cancer chemo-immunotherapy approach mediated by synergistic CD326 targeted porous silicon nanovectorsWhat Is the Role of Nanotechnology in Diagnosis and Treatment of Metastatic Breast Cancer? Promising Scenarios for the Near FutureUse of Magnetic Nanoparticles as Targeted Therapy: Theranostic Approach to Treat and Diagnose Cancer
P2860
Q27026630-D5FBE022-0BC2-48B1-AE99-623FF7988E32Q30409983-334186A0-20DC-48CF-AC0E-D730C54C549DQ31004643-309E1219-CBA7-4118-B233-64FF03F6FCA2Q33649880-BEFE530E-3328-4E48-87B2-ABC33D233B61Q34079536-F653884F-E2AF-447A-AF62-70402EFE7B59Q35563975-63C1BEC7-0D1E-4C12-9D17-067047B3C779Q36357291-5D741389-3EA5-4492-89B1-3AE465D8DD8AQ36395999-B5D0227D-6527-43C5-827C-04CAB398FF83Q37702718-D198A0DE-229E-4AC1-81CF-5F4F0C835EE6Q37738222-A24C5783-BF97-424A-8D69-2F118DB89EE8Q38665261-C4E7EFB8-7EA7-4767-BC0C-114A8C392839Q38676164-DFDB5356-889A-47BC-9D4A-DA7B79962FADQ38928745-034A64EB-B93F-453E-9220-4F8CE65804DFQ42262385-A1DDCCC8-7D3D-4D68-8BD7-00949CDE45D1Q50941105-D005DF9A-A989-4C5A-9682-0B6C2AD742EEQ51053595-432A71D3-55E8-460B-8BFB-FD1999C87323Q52614694-8E8BA1CA-1739-4D26-8218-ADA020E19F77Q52716381-64C5C0C1-96EA-4B69-BCB5-0159D1D9751EQ57570718-F79C290A-6E85-4C3D-94DF-19549ECF10C4Q59128232-EDF978ED-CB2D-4FD7-B9BB-00A041261EBBQ59146850-0C375D91-357A-416C-8958-EDE73196295E
P2860
Assessing the in vivo targeting efficiency of multifunctional nanoconstructs bearing antibody-derived ligands.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Assessing the in vivo targetin ...... ring antibody-derived ligands.
@en
Assessing the in vivo targetin ...... ring antibody-derived ligands.
@nl
type
label
Assessing the in vivo targetin ...... ring antibody-derived ligands.
@en
Assessing the in vivo targetin ...... ring antibody-derived ligands.
@nl
prefLabel
Assessing the in vivo targetin ...... ring antibody-derived ligands.
@en
Assessing the in vivo targetin ...... ring antibody-derived ligands.
@nl
P2093
P50
P356
P1433
P1476
Assessing the in vivo targetin ...... ring antibody-derived ligands.
@en
P2093
Davide Prosperi
Michela Bellini
Raffaele Allevi
Silvia Sommaruga
P304
P356
10.1021/NN4018922
P407
P577
2013-06-12T00:00:00Z